TAMPA, Fla., Nov. 11, 2025 /PRNewswire/ — Veterans Day – The Office of the Assistant Secretary of War (OASW) for Special Operations / Low-Intensity Conflict (SO/LIC) Capability Development & Innovation (CD&I) Directorate competitively awarded XTEND Reality Inc., a multi-million-dollar Firm Fixed Price Contract to rapidly develop and deliver Affordable Close Quarter Modular Effects FPV Drone Kits …

Pfizer has won a $10 billion bidding war for Metsera, beating Novo Nordisk, which withdrew due to antitrust concerns. Hanmi's Efpeglenatide Phase 3 results show promising weight loss and fewer side effects compared to competitors. Eli Lilly is moving forward with its oral GLP-1 candidate, orforglipron, while its tirzepatide continues to dominate sales, surpassing Merck’s Keytruda. Meanwhile, Wave Life Sciences reports significant progress with its RNAi therapy for obesity. Korea’s MFDS is reviewing potential misuse concerns surrounding obesity drugs like Wegovy.

Another of the psychiatry drugs Neurocrine licensed from Takeda has stumbled in the clinic.

Fabric, the New York-based health IT startup that provides software to help doctors conduct virtual appointments and automate the administrative work around them, like scheduling and taking stock of symptoms, has bought UCM Digital Health ...

China has introduced a new contender in the affordable electric vehicle (EV) market: the Aion UT Super, a compact, fully electric car developed through a collaboration between GAC Group, CATL, and JD.com. Sold exclusively online through JD.com, the model aims to redefine the concept of low-cost and smart mobility. The pricing strategy is one of its most attractive features. Consumers can either purchase the vehicle without a battery for about €5,000 (around $5,400) and pay a monthly battery rental of €50 (around $54), or buy both the car and the battery together for approximately €10,000 (around $10,800). This flexible ownership model is designed to make EV adoption more accessible to a broader audience. In terms of design, the Aion UT Super retains the silhouette of the earlier 2020 Aion UT, featuring a hatchback body with a sporty, aerodynamic profile. Its front end displays four-point LED headlights and diagonal air intakes, giving it a youthful appearance. It is available in two color options—Monet Purple and Champs-Élysées Beige. The vehicle measures 4.2 meters (13.8 ft) in length, 1.8 meters (5.9 ft) in width, and 1.57 meters (5.2 ft) in height, with a wheelbase of 2.7 meters (8.9 ft), ensuring a relatively spacious interior for a compact car. Inside, the UT Super offers a minimalist and tech-forward cabin. It features an 8.8-inch digital instrument cluster and a 14.6-inch central touchscreen, both integrated with Huawei Cloud technology. The system supports AI voice commands and is compatible with HarmonyOS, Apple, and Android platforms, providing a smooth and connected user experience. Comfort and convenience are emphasized through front seats that recline up to 180 degrees, a 540° panoramic camera, parking sensors, and a six-speaker audio system. Under the hood, the Aion UT Super is equipped with a 100 kW (134 hp) electric motor, powered by a CATL LFP battery, delivering a range of approximately 500 km (310 miles) under China’s CLTC testing cycle. The most remarkable feature, however, is its battery-swapping capability—a technology that allows the battery to be replaced in just 99 seconds. This innovation could dramatically reduce charging downtime and make electric mobility far more practical, positioning China as a leader in the next phase of EV development. Aion UT Super EV Unveiled For $5,400 With 99-Second Battery Swap , original content from Ubergizmo. Read our Copyrights and terms of use.

Voodoo Scientific has developed a process that, when applied to fiery hooch, results in a more sippable tipple.

Lucid Diligence Brief: Galecto acquires Damora Therapeutics Professional audiences only. Not investment research or advice. UK readers: for persons under […] The post Lucid Diligence Brief: Galecto acquires Damora Therapeutics appeared first on LucidQuest Ventures.

RNA-Based Gene Therapy Offers New Hope For ALS Patients  Mirage News

Accenture and Apptio expand business partnership to help organizations maximize technology investments NEW YORK–(BUSINESS WIRE)–Accenture (NYSE: ACN) and Apptio are working with PPL Corporation, a U.S. energy company providing electricity and natural gas to more than 3.6 million customers in the U.S., to transform how the company prioritizes and manages technology spending—all in support of …

EnGene has posted another tranche of encouraging bladder cancer treatment data from a pivotal trial, teeing up a BLA filing in the back half of next year. The company said that the gene therapy, called ...

Pathology supplier Synnovis is contacting NHS organisations which had data stolen and published online following a major cyber attack.

While for years patient engagement has been seen as a valuable, starting in 2026 this will be a legal mandate. Plans offering essential health benefits must appoint at least 1 patient representative to their pharmacy and therapeutics (P&T) committees by the start of 2026.1 After July 10, 2026, every state Medicaid program must establish standalone Beneficiary…

How do you build a single speech recognition system that can understand 1,000’s of languages including many that never had working ASR (automatic speech recognition) models before? Meta AI has released Omnilingual ASR, an open source speech recognition suite that scales to more than 1,600 languages and can be extended to unseen languages with only […] The post Meta AI Releases Omnilingual ASR: A Suite of Open-Source Multilingual Speech Recognition Models for 1600+ Languages appeared first on MarkTechPost.

Associate Professor Phillip Isola studies the ways in which intelligent machines “think,” in an effort to safely integrate AI into human society.

Fill in this form and get your report right now! Gain access to the onco / hem indications and the most popular mechanisms of action the leading BioPharma companies have been targeting and pursuing as at Q1 2025 (and beyond). In this concise report, we share the findings of the analysis of the portfolios and pipelines of 15 oncology and hematology companies and present a space overview and individual company profiles. Contact us at info@lqventures.com for more information or any other feedback. LucidQuest is committed to empowering its BioPharma and Life Sciences Investment industry stakeholders with up-to-date knowledge and analysis. Stay tuned for more free reports coming up in 2025 covering Cell and Gene Therapy, Multiple Sclerosis, Digital Health, Venture Capital investment in Pharma, and other spaces. The LucidQuest team

This biweekly obesity video recap reviews major moves shaping the obesity and metabolic landscape—from strategic deals and late-stage data to […] The post Obesity Video Recap—November 11, 2025 appeared first on LucidQuest Ventures.

This week in endocrinology: fresh clinical readouts, market-moving industry moves, and updates from top biopharma players. In Today’s Newsletter Dive […] The post Endocrinology Today—November 11, 2025 appeared first on LucidQuest Ventures.

LONDON–(BUSINESS WIRE)–#Display–Overall display area demand is projected to grow 6% year-over-year in 2026, according to Omdia’s Display long-term demand forecast tracker. While unit growth is expected to decline by 2% due to uncertainty surrounding US import tariff policies and a slowing economic growth rate, area growth is expected to remain robust, driven by increased demand …

Track this week’s obesity headlines: Obesity Week 2025 highlights, industry activity, clinical milestones, and biopharma breakthroughs. In this Newsletter Dive […] The post Obesity Today—November 11, 2025 appeared first on LucidQuest Ventures.

What You Should Know:  – Cigna Healthcare, the health benefits division of The Cigna Group, is significantly expanding its behavioral health offerings through an industry-first collaboration with Headspace. This partnership is designed to address the increasing rates of anxiety, stress, burnout, and sleep issues affecting the modern workforce. – Millions of Cigna Healthcare customers will ... Read More

Strategic Insights and Consulting to Succeed in Vaccines

Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Professional audiences only. Not investment research or advice. UK readers: […] The post Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery appeared first on LucidQuest Ventures.

NEW YORK & STOCKHOLM–(BUSINESS WIRE)–Essity (STO: ESSITY-B) has selected Accenture (NYSE: ACN) and Microsoft to help the global hygiene and health company accelerate the use of AI agents to unlock value and drive efficiencies and growth through improved business agility. As part of the multi-year collaboration, the companies will work together at Essity’s AI Centre …

In this tutorial, we explore how to build and train an advanced neural network using JAX, Flax, and Optax in an efficient and modular way. We begin by designing a deep architecture that integrates residual connections and self-attention mechanisms for expressive feature learning. As we progress, we implement sophisticated optimization strategies with learning rate scheduling, […] The post A Coding Implementation to Build and Train Advanced Architectures with Residual Connections, Self-Attention, and Adaptive Optimization Using JAX, Flax, and Optax appeared first on MarkTechPost.

New Research On Gene Editing Therapy May Cut Cholesterol, Triglycerides By Half  NDTV